Search - tctmd.com

Displaying 401 - 413 of 413

Sort: Relevancy | Date

News Daily News

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Caitlin E. Cox

October 27, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

News Industry News

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

July 09, 2015

News Daily News

大多数美国患者在急性心肌梗死后出院时仍被开出高剂量阿司匹林

Todd Neale

August 20, 2014

News Daily News

Majority of US Patients Still Discharged on High-Dose Aspirin After Acute MI

Todd Neale

August 20, 2014

News Daily News

La Mayoría de Pacientes de EE.UU. siguen recibiendo el Alta Hospitalaria con Dosis Altas de Aspirina tras Sufrir un IAM

Todd Neale

August 20, 2014

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

News Daily News

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Caitlin E. Cox

October 04, 2013

News Daily News

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

Caitlin E. Cox

December 16, 2012

News Daily News

El Control del Factor de Riesgo se asocia a Mejores Resultados tras una Intervención Periférica

Caitlin E. Cox

December 16, 2012

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

News Daily News

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Caitlin E. Cox

July 12, 2012

News Daily News

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Caitlin E. Cox

May 10, 2011

Advertisement

No Money, No Drugs: Global Barriers to Secondary CVD Prevention

Discussion Highlights Merits, Limitations of Small Trials

The Medicines Company Authorizes Generic Launch of ANGIOMAX® (bivalirudin)

大多数美国患者在急性心肌梗死后出院时仍被开出高剂量阿司匹林

Majority of US Patients Still Discharged on High-Dose Aspirin After Acute MI

La Mayoría de Pacientes de EE.UU. siguen recibiendo el Alta Hospitalaria con Dosis Altas de Aspirina tras Sufrir un IAM

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

El Control del Factor de Riesgo se asocia a Mejores Resultados tras una Intervención Periférica

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

A los 10 Años el Apixaban resulta Más Barato que la Aspirina para la Prevención de ACV en Pacientes con FA

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content